DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Ludolph AC, Schuster J, Dorst J. et al
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
The Lancet Neurology 2018;
17: 681-688
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.